E-LIB Suche - Ergebnisse für: Puente, Javier

1

Management of Adverse Reactions Related to Lenvatinib Plus ..:

Grünwald, Viktor ; Larkin, James ; Puente, Javier..
Clinical Genitourinary Cancer. 22 (2024) 2 - p. 394-401 , 2024

Link: https://doi.org/10.1016/..

2

CRISPR/Cas9 screenings unearth protein arginine methyltrans..:

Rodrigo-Faus, Maria ; Vincelle-Nieto, Africa ; Vidal, Natalia...
Cancer Letters. 588 (2024) - p. 216776 , 2024

Link: https://doi.org/10.1016/..

3

Assessment Model of Industry 5.0 Implementation in Small an..:

, In: Proceedings of the 17th International Conference on Industrial Engineering and Industrial Management (ICIEIM) – XXVII Congreso de Ingeniería de Organización (CIO2023); Lecture Notes on Data Engineering and Communications Technologies,

Perez Bernardo, Jose Manuel ; Puente, Javier ; León, Omar. - p. 155-160 , 2024

Link: https://doi.org/10.1007/..

4

Characterization of Responses to Lenvatinib plus Pembrolizu..:

Motzer, Robert J. ; Choueiri, Toni K. ; Hutson, Thomas...
European Urology. 86 (2024) 1 - p. 4-9 , 2024

Link: https://doi.org/10.1016/..

5

Molecularly Defined Renal Carcinomas:

Amann-Arévalo, Marta ; Ballestín Martínez, Pablo ; Vidal Cassinello, Natalia...
Kidney Cancer. 8 (2024) 1 - p. 31-44 , 2024

Link: https://doi.org/10.3233/..

6

Criteria and indicators to evaluate quality of care in geni..:

Puente, Javier ; Algaba Arrea, Ferrán ; Buisán Rueda, Óscar...
Clinical and Translational Oncology. 26 (2024) 7 - p. 1639-1646 , 2024

Link: https://doi.org/10.1007/..

7

Prospective Assessment of Bone Metabolism Biomarkers and Su..:

Romero-Laorden, Nuria ; Lorente, David ; de Velasco, Guillermo...
European Urology Oncology. 7 (2024) 3 - p. 447-455 , 2024

Link: https://doi.org/10.1016/..

8

Capmatinib plus nivolumab in pretreated patients with EGFR ..:

Felip, Enriqueta ; Metro, Giulio ; Tan, Daniel S.W....
Lung Cancer. 192 (2024) - p. 107820 , 2024

Link: https://doi.org/10.1016/..

9

Assessing exposure to wind turbines of a migratory raptor t..:

Assandri, Giacomo ; Bazzi, Gaia ; Bermejo-Bermejo, Ana...
Biological Conservation. 293 (2024) - p. 110592 , 2024

Link: https://doi.org/10.1016/..

10

Atezolizumab monotherapy versus chemotherapy in untreated l..:

Bamias, Aristotelis ; Davis, Ian D ; Galsky, Matthew D...
The Lancet Oncology. 25 (2024) 1 - p. 46-61 , 2024

Link: https://doi.org/10.1016/..

11

Atezolizumab plus chemotherapy versus placebo plus chemothe..:

Grande, Enrique ; Arranz, José Á ; De Santis, Maria...
The Lancet Oncology. 25 (2024) 1 - p. 29-45 , 2024

Link: https://doi.org/10.1016/..

12

Prognostic Implications of Blood Immune-Cell Composition in..:

Perez-Navarro, Enrique ; Conteduca, Vincenza ; Funes, Juan M....
Cancers. 16 (2024) 14 - p. 2535 , 2024

Link: https://doi.org/10.3390/..

13

Integrated model for the assessment of power generation alt..:

Rivero-Iglesias, Jose M. ; Puente, Javier ; Fernandez, Isabel.
Renewable Energy. 211 (2023) - p. 563-581 , 2023

Link: https://doi.org/10.1016/..

14

Assessing Industry 4.0 Readiness: The Influence of Drivers ..:

, In: 2023 Congress in Computer Science, Computer Engineering, & Applied Computing (CSCE),

Leon, Omar ; Puente, Javier ; Fernandez, Isabel. - p. 429-433 , 2023

Link: https://doi.org/10.1109/..

15

Darolutamide in Spanish patients with nonmetastatic castrat..:

Carles, Joan ; Medina-Lopez, Rafael A ; Puente, Javier...
Future Oncology. 19 (2023) 12 - p. 819-828 , 2023

Link: https://doi.org/10.2217/..